Clinical challenges facing patient participation in cardiac rehabilitation: cigarette smoking

References

• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association. Circulation. 2009;143(8):e254–e743.
   Google Scholar
• Mons U, Müezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015 Apr 20;350(apr20 2):h1551–h1551. doi: 10.1136/bmj.h1551
   PubMedGoogle Scholar
• Boggon R, Timmis A, Hemingway H, et al. Smoking cessation interventions following acute coronary syndrome: a missed opportunity? Eur J Prev Cardiol. 2014;21(6):767–773. doi: 10.1177/2047487312460517
   PubMed Web of Science ®Google Scholar
• Breitling LP, Rothenbacher D, Vossen CY, et al. Validated smoking cessation and prognosis in patients with stable coronary heart disease. J Am Coll Cardiol. 2011;58(2):196–197. doi: 10.1016/j.jacc.2011.01.045
   PubMed Web of Science ®Google Scholar
• Hasdai D, Garratt KN, Grill DE, et al. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336(11):755–761. doi: 10.1056/NEJM199703133361103
   PubMed Web of Science ®Google Scholar
• Twardella D, Küpper-Nybelen J, Rothenbacher D, et al. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. Eur Heart J. 2004;25(23):2101–2108. doi: 10.1016/j.ehj.2004.08.017
   PubMed Web of Science ®Google Scholar
• Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290(1):86–97. doi: 10.1001/jama.290.1.86
   PubMed Web of Science ®Google Scholar
• Wilson K, Gibson N, Willan A, et al. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med. 2000;160(7):939–944. doi: 10.1001/archinte.160.7.939
   PubMedGoogle Scholar
• Perk J, De Backer G, Gohlke H, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012) the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) developed with the special contribution of the European Association for cardiovascular prevention & rehabilitation (EACPR). Eur J Prev Cardiol. 2012;19(4):585–667.
   PubMed Web of Science ®Google Scholar
• SC S Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American heart association and American college of cardiology foundation endorsed by the world heart federation and the preventive cardiovascular nurses association. J Am Coll Cardiol. 2011;58(23):2432–2446. doi: 10.1016/j.jacc.2011.10.824
   PubMed Web of Science ®Google Scholar
• Gaalema DE, Pericot-Valverde I, Bunn JY, et al. Tobacco use in cardiac patients: perceptions, use, and changes after a recent myocardial infarction among US adults in the PATH study (2013-2015). Prev Med. 2018;117:76–82. doi: 10.1016/j.ypmed.2018.05.004
   PubMed Web of Science ®Google Scholar
• Colivicchi F, Mocini D, Tubaro M, et al. Effect of smoking relapse on outcome after acute coronary syndromes. Am J Cardiol. 2011;108(6):804–808. doi: 10.1016/j.amjcard.2011.04.033
   PubMed Web of Science ®Google Scholar
• Mussulman LM, Scheuermann TS, Faseru B, et al. Rapid relapse to smoking following hospital discharge. Prev Med Rep. 2019;15:100891. doi: 10.1016/j.pmedr.2019.100891
   PubMedGoogle Scholar
• US Department of Health and Human Services. The health consequences of smoking-50 years of progress: a report of the Surgeon general. In: Reports of the Surgeon General. Atlanta GA; 2014. https://www.ncbi.nlm.nih.gov/books/NBK179276/
   Google Scholar
• Gaalema DE, Bolívar HA, Khadanga S, et al. Current smoking as a marker of a high-risk behavioral profile after myocardial infarction. Prev Med. 2020;140:106245. doi: 10.1016/j.ypmed.2020.106245
   PubMed Web of Science ®Google Scholar
• Balady GJ, Ades PA, Bittner VA, et al. Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American heart association. Circulation. 2011;124(29):2951–2960. doi: 10.1161/CIR.0b013e31823b21e2
   PubMedGoogle Scholar
• Dibben G, Faulkner J, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2021;11(11): CD001800. doi: 10.1002/14651858.CD001800.pub4
   PubMedGoogle Scholar
• Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345(12):892–902. doi: 10.1056/NEJMra001529
   PubMed Web of Science ®Google Scholar
• Grace SL, Abbey SE, Shnek ZM, et al. Cardiac rehabilitation I: review of psychosocial factors. Gen Hosp Psychiatry. 2002;24(3):121–126. doi: 10.1016/S0163-8343(02)00178-0
   PubMed Web of Science ®Google Scholar
• Swift DL, Lavie CJ, Johannsen NM, et al. Physical activity, cardiorespiratory fitness, and exercise training in primary and secondary coronary prevention. Circ J. 2013;77(2):281–292. doi: 10.1253/circj.CJ-13-0007
   PubMed Web of Science ®Google Scholar
• Gaalema DE, Cutler AY, Higgins ST, et al. Smoking and cardiac rehabilitation participation: associations with referral, attendance and adherence. Prev Med. 2015;80:67–74. doi: 10.1016/j.ypmed.2015.04.009
   PubMed Web of Science ®Google Scholar
• Gaalema DE, Savage PD, Rengo JL, et al. Patient characteristics predictive of cardiac rehabilitation adherence. J Cardiopulm Rehabil Prev. 2017;37(2):103–110. doi: 10.1097/HCR.0000000000000225
   PubMed Web of Science ®Google Scholar
• Pack QR, Visintainer P, Farah M, et al. Development of a simple clinical tool for predicting early dropout in cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2021;41(3):159. doi: 10.1097/HCR.0000000000000541
   PubMed Web of Science ®Google Scholar
• Hammill BG, Curtis LH, Schulman KA, et al. Relationship between cardiac rehabilitation and long-term risks of death and myocardial infarction among elderly Medicare beneficiaries. Circulation. 2010;121(1):63–70. doi: 10.1161/CIRCULATIONAHA.109.876383
   PubMed Web of Science ®Google Scholar
• Suaya JA, Stason WB, Ades PA, et al. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;200954(1):25–33. doi: 10.1016/j.jacc.2009.01.078
   Google Scholar
• Borg S, Öberg B, Leosdottir M, et al. Factors associated with non-attendance at exercise-based cardiac rehabilitation. BMC Sports Sci Med Rehabil. 2019;11(1):1–0. doi: 10.1186/s13102-019-0125-9
   PubMed Web of Science ®Google Scholar
• Gaalema DE, Elliott RJ, Morford ZH, et al. Effect of socioeconomic status on propensity to change risk behaviors following myocardial infarction: implications for healthy lifestyle medicine. Prog Cardiovasc Dis. 2017;60(1):159–168. doi: 10.1016/j.pcad.2017.01.001
   PubMed Web of Science ®Google Scholar
• Fluharty M, Taylor AE, Grabski M, et al. The association of cigarette smoking with depression and anxiety: a systematic review. Nicotine Tobacco Res. 2016;19(1):3–13. doi: 10.1093/ntr/ntw140
   PubMed Web of Science ®Google Scholar
• Gaffey AE, Goldstein CM, Hays MM, et al. Psychological risk factors in cardiac rehabilitation: anxiety, depression, social isolation, and anger/hostility. J Cardiopulm Rehabil Prev. 2023;43(6):E20–E21. doi: 10.1097/HCR.0000000000000828
   PubMed Web of Science ®Google Scholar
• Oldridge NB, Donner AP, Buck CW, et al. Predictors of dropout from cardiac exercise rehabilitation: Ontario Exercise-Heart Collaborative Study. Am J Cardiol. 1983;51(1):70–74. doi: 10.1016/S0002-9149(83)80013-7
   PubMed Web of Science ®Google Scholar
• Wittmer M, Volpatti M, Piazzalonga S, et al. Expectation, satisfaction, and predictors of dropout in cardiac rehabilitation. Eur J Prev Cardiol. 2012;19(5):1082–1088. doi: 10.1177/1741826711418163
   PubMed Web of Science ®Google Scholar
• Sven G, Koch B, Ittermann T, et al. Influence of age, sex, body size, smoking, and β blockade on key gas exchange exercise parameters in an adult population. Eur J Prev Cardiol. 2010;17(4):469–476. doi: 10.1097/HJR.0b013e328336a124
   Google Scholar
• Smarz K, Zaborska B, Jaxa-Chamiec T, et al. Right ventricular dysfunction and exercise capacity after inferior (posterior) wall acute myocardial infarction. Am J Cardiol. 2012;110(6):784–789. doi: 10.1016/j.amjcard.2012.05.007
   PubMed Web of Science ®Google Scholar
• Tzou W, Vitcenda M, McBride P. Smoking status after cardiac events and participation in outpatient cardiac rehabilitation. J Cardiopulm Rehabil Prev. 2004;24(2):94–99. doi: 10.1097/00008483-200403000-00005
   Google Scholar
• Johnston DW, Johnston M, Pollard B, et al. Motivation is not enough: prediction of risk behavior following diagnosis of coronary heart disease from the theory of planned behavior. Health Psychol. 2004;23(5):533. doi: 10.1037/0278-6133.23.5.533
   PubMed Web of Science ®Google Scholar
• Grace SL, Abbey SE, Pinto R, et al. Longitudinal course of depressive symptomatology after a cardiac event: effects of gender and cardiac rehabilitation. Psychosom Med. 2005;67(1):52. doi: 10.1097/01.psy.0000151486.28349.70
   PubMed Web of Science ®Google Scholar
• Riley H, Headley S, Lindenauer PK, et al. Patient perception of how smoking status influences cardiac rehabilitation attendance after an acute cardiac hospitalization. J Cardiopulm Rehabil Prev. 2019;39(3):181. doi: 10.1097/HCR.0000000000000366
   PubMed Web of Science ®Google Scholar
• Kaminsky LA, Arena R, Ellingsen Ø, et al. Cardiorespiratory fitness and cardiovascular disease – the past, present, and future. Prog Cardiovasc Dis. 2019;62(2):86–93. doi: 10.1016/j.pcad.2019.01.002
   PubMed Web of Science ®Google Scholar
• Rengo JL, Savage PD, Hirashima F, et al. Assessment of the early disabling effects of coronary artery bypass graft surgery using direct measures of physical function. J Cardiopulm Rehabil Prev. 2022;42(1):28–33. doi: 10.1097/HCR.0000000000000587
   PubMed Web of Science ®Google Scholar
• Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term prognosis in 12169 men referred for cardiac rehabilitation. Circulation. 2002;106(6):666–671. doi: 10.1161/01.CIR.0000024413.15949.ED
   PubMed Web of Science ®Google Scholar
• Hughes JR, Crow RS, DR J Jr, et al. Physical activity, smoking, and exercise-induced fatigue. J Behav Med. 1984;7(2):217–230. doi: 10.1007/BF00845388
   PubMed Web of Science ®Google Scholar
• Tantisuwat A, Thaveeratitham P. Effects of smoking on chest expansion, lung function, and respiratory muscle strength of youths. J Phys Ther Sci. 2014;26(2):167–170. doi: 10.1589/jpts.26.167
   PubMedGoogle Scholar
• Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004;43(10):1731–1737. doi: 10.1016/j.jacc.2003.12.047
   PubMed Web of Science ®Google Scholar
• Asthana A, Piper ME, McBride PE, et al. Long-term effects of smoking and smoking cessation on exercise stress testing: three-year outcomes from a randomized clinical trial. Am Heart J. 2012;163(1):81–87. doi: 10.1016/j.ahj.2011.06.023
   PubMed Web of Science ®Google Scholar
• Gläser S, Koch B, Ittermann T, et al. Influence of age, sex, body size, smoking, and β blockade on key gas exchange exercise parameters in an adult population. Eur J Cardiovasc Prev Rehabil. 2010;7(4):469–476. doi: 10.1097/HJR.0b013e328336a124
   Google Scholar
• Hashizume K, Yamaji K, Kusaka Y, et al. Effects of abstinence from cigarette smoking on the cardiorespiratory capacity. Med Sci Sports Exerc. 2000;32(2):386–391. doi: 10.1097/00005768-200002000-00019
   PubMed Web of Science ®Google Scholar
• Weinberger AH, Mazure CM, McKee SA, et al. The association of tobacco use and gender to cardiac rehabilitation outcomes: a preliminary investigation. J Subst Use. 2014;19(1–2):171–175. doi: 10.3109/14659891.2013.765515
   PubMed Web of Science ®Google Scholar
• Oldridge N, Gottlieb M, Guyatt G, et al. Predictors of health-related quality of life with cardiac rehabilitation after acute myocardial infarction. J Cardiopulm Rehabil Prev. 1998;18(2):95–103. doi: 10.1097/00008483-199803000-00002
   Google Scholar
• Mlakar P, Salobir B, Cobo N, et al. Influence of short-term cardiac rehabilitation on oxidative stress in men after myocardial infarction depends upon smoking status. J Cardiopulm Rehabil Prev. 2013;33(6):401–405. doi: 10.1097/HCR.0000000000000016
   PubMed Web of Science ®Google Scholar
• Digenio AG, Padayachee N, Groeneveld H. Multivariate models for compliance with phase 3 cardiac rehabilitation services in Johannesburg. Ann Acad Med Singap. 1992;21(1):121–127.
   PubMedGoogle Scholar
• Aparici M, FG AL, Alegria E. Aerobic capacity. Differences between smokers and non-smokers. Effects of withdrawal. Rev Clin Esp. 1993;193(8):424–427.
   PubMed Web of Science ®Google Scholar
• Salman A, Doherty P. Predictors of quitting smoking in cardiac rehabilitation. J Clin Med. 2020;9(8):2612. doi: 10.3390/jcm9082612
   PubMed Web of Science ®Google Scholar
• Gallus S, Tramacere I, Boffetta P, et al. Temporal changes of under-reporting of cigarette consumption in population-based studies. Tob Control. 2011;20(1):34–39. doi: 10.1136/tc.2009.034132
   PubMed Web of Science ®Google Scholar
• Mooren K, van der Linden GG, Pool K, et al. The attitudes of pulmonologists regarding smoking behavior of their patients with advanced international journal of chronic obstructive pulmonary disease: a qualitative research. COPD. 2019;Volume 14:2673–2679. doi: 10.2147/COPD.S216274
   Google Scholar
• From Attebring M, Herlitz J, Berndt AK, et al. Are patients truthful about their smoking habits? A validation of self‐report about smoking cessation with biochemical markers of smoking activity amongst patients with ischaemic heart disease. J Intern Med. 2001;249(2):145–151. doi: 10.1046/j.1365-2796.2001.00770.x
   PubMed Web of Science ®Google Scholar
• Gerritsen M, Berndt N, Lechner L, et al. Self-reporting of smoking cessation in cardiac patients: how reliable is it and is reliability associated with patient characteristics? J Addict Med. 2015;9(4):308–316. doi: 10.1097/ADM.0000000000000137
   PubMed Web of Science ®Google Scholar
• Levy AG, Scherer AM, Zikmund-Fisher BJ, et al. Prevalence of and factors associated with patient nondisclosure of medically relevant information to clinicians. JAMA Netw Open. 2018;1(7):e185293–. doi: 10.1001/jamanetworkopen.2018.5293
   PubMed Web of Science ®Google Scholar
• Curry LE, Richardson A, Xiao H, et al. Nondisclosure of smoking status to health care providers among current and former smokers in the United States. Health Educ Behav. 2013;40(3):266–273. doi: 10.1177/1090198112454284
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Bernert JT, Foulds J, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tobacco Res. 2020;22(7):1086–1097. doi: 10.1093/ntr/ntz132
   PubMed Web of Science ®Google Scholar
• Deveci SE, Deveci F, Açik Y, et al. The measurement of exhaled carbon monoxide in healthy smokers and non-smokers. Respir med. 2004;98(6):551–556. doi: 10.1016/j.rmed.2003.11.018
   PubMed Web of Science ®Google Scholar
• Barn P, Giles L, Héroux ME, et al. A review of the experimental evidence on the toxicokinetics of carbon monoxide: the potential role of pathophysiology among susceptible groups. Environ Health. 2018;17(1):1–1. doi: 10.1186/s12940-018-0357-2
   PubMedGoogle Scholar
• Gandini C, Castoldi AF, Candura SM, et al. Carbon monoxide cardiotoxicity. J Toxicol Clin Toxicol. 2001;39(1):35–44. doi: 10.1081/CLT-100102878
   PubMed Web of Science ®Google Scholar
• Gaalema DE, Yant B, Khadanga S, et al. Carbon monoxide monitoring to objectively measure smoking status in cardiac rehabilitation. Health Psychol. 2022 Apr 7;41(10):733–739. doi: 10.1037/hea0001178
   PubMed Web of Science ®Google Scholar
• Gaalema DE. Carbon monoxide and its effects on those with cardiovascular disease. J Cardiopulm Rehabil Prev. 2022;42(5):E55–6. doi: 10.1097/HCR.0000000000000733
   PubMed Web of Science ®Google Scholar
• Rigotti NA, Clair C, Munafò MR, et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012;2012(5). doi: 10.1002/14651858.CD001837.pub3
   Google Scholar
• Jeong SM, Jeon KH, Shin DW, et al. Smoking cessation, but not reduction, reduces cardiovascular disease incidence. Eur Heart J. 2021;42(40):4141–4153. doi: 10.1093/eurheartj/ehab578
   PubMed Web of Science ®Google Scholar
• Barua RS, Rigotti NA, Benowitz NL, et al. ACC expert consensus decision pathway on tobacco cessation treatment: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2018;72(25):3332–3365. doi: 10.1016/j.jacc.2018.10.027
   PubMed Web of Science ®Google Scholar
• Cahill K, Lindson-Hawley N, Thomas KH, et al. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2016. CD006103. doi: 10.1002/14651858.CD006103.pub7.
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ, Blum LM, Filion KB, et al. The efficacy of smoking cessation therapies in cardiac patients: a meta-analysis of randomized controlled trials. Can J Cardiol. 2010;26(2):73–79. doi: 10.1016/S0828-282X(10)70002-7
   PubMed Web of Science ®Google Scholar
• Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11. CD000146.
   PubMedGoogle Scholar
• McCrabb S, Baker AL, Attia J, et al. Hospital smoke-free policy: compliance, enforcement, and practices. A staff survey in two large public hospitals in Australia. Int J Environ Res Public Health. 2017;14(11):1358. doi: 10.3390/ijerph14111358
   PubMed Web of Science ®Google Scholar
• Dohnke B, Ziemann C, Will KE, et al. Do hospital treatments represent a ‘teachable moment’ for quitting smoking? A study from a stage-theoretical perspective. Psychology & Health. 2012;27(11):1291–1307. doi: 10.1080/08870446.2012.672649
   PubMed Web of Science ®Google Scholar
• Riley H, Ainani N, Turk A, et al. Smoking cessation after hospitalization for myocardial infarction or cardiac surgery: assessing patient interest, confidence, and physician prescribing practices. Clin Cardiol. 2019;42(12):1189–1194. doi: 10.1002/clc.23272
   PubMedGoogle Scholar
• Fiore MC, Adsit R. Will hospitals finally “do the right thing”? Providing evidence-based tobacco dependence treatments to hospitalized patients who smoke. Jt Comm J Qual Patient Saf. 2016;42(5):207–208. doi: 10.1016/S1553-7250(16)42026-X
   PubMedGoogle Scholar
• Leone FT, Zhang Y, Evers-Casey S, et al. Initiating pharmacologic treatment in tobacco-dependent adults. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;202(2):e5–31. doi: 10.1164/rccm.202005-1982ST
   PubMed Web of Science ®Google Scholar
• Lovatt S, Wong CW, Holroyd E, et al. Smoking cessation after acute coronary syndrome: a systematic review and meta‐analysis. Int J Clin Pract. 2021;75(12):e14894. doi: 10.1111/ijcp.14894
   PubMed Web of Science ®Google Scholar
• Lindson N, Chepkin SC, Ye W, et al. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2019;4(4): CD013308. doi: 10.1002/14651858.CD013308
   PubMedGoogle Scholar
• Campbell IA, Prescott RJ, Tjeder-Burton SM. Smoking cessation in hospital patients given repeated advice plus nicotine or placebo chewing gum. Respir med. 1991;85(2):155–157. doi: 10.1016/S0954-6111(06)80295-7
   PubMed Web of Science ®Google Scholar
• Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996;335(24):1792–1798. doi: 10.1056/NEJM199612123352402
   PubMed Web of Science ®Google Scholar
• Eisenberg MJ, Windle SB, Roy N, et al. Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome. Circulation. 2016;133(1):21–30. doi: 10.1161/CIRCULATIONAHA.115.019634
   PubMed Web of Science ®Google Scholar
• Le Mao R, Tromeur C, Paleiron N, et al. Effect of early initiation of varenicline on smoking cessation in COPD patients admitted for exacerbation: the save randomized clinical trial. COPD: J Chronic Obstructive Pulmonary Dis. 2019;17(1):1–8. doi: 10.1080/15412555.2019.1703928
   Web of Science ®Google Scholar
• Fouz‐Rosón N, Montemayor‐Rubio T, Almadana‐Pacheco V, et al. Effect of 0.5 mg versus 1 mg varenicline for smoking cessation: a randomized controlled trial. Addiction. 2017;112(9):1610–1619. doi: 10.1111/add.13855
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Hukkanen J, Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield JE, London ED, Pogun S, editors. Nicot Psycho. Vol 192, Handbook of Experimental Pharmacology. Berlin, Heidelberg: Springer; 2009. p. 29–60.
   Google Scholar
• Mills EJ, Wu P, Lockhart I, et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Dis. 2010;8(1):1–5. doi: 10.1186/1617-9625-8-8
   PubMedGoogle Scholar
• Thomas D, Abramson MJ, Bonevski B, et al. Quitting experiences and preferences for a future quit attempt: a study among inpatient smokers. BMJ Open. 2015;5(4):e006959. doi: 10.1136/bmjopen-2014-006959
   PubMed Web of Science ®Google Scholar
• Chang PH, Chiang CH, Ho WC, et al. Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health. 2015;15(1):689. doi: 10.1186/s12889-015-2055-0
   PubMedGoogle Scholar
• Vogeler T, McClain C, Evoy KE. Combination bupropion sr and varenicline for smoking cessation: a systematic review. Am J Drug Alcohol Abuse. 2016;42(2):129–139. doi: 10.3109/00952990.2015.1117480
   PubMed Web of Science ®Google Scholar
• Ebbert JO, Hays JT, Hurt RD. Combination pharmacotherapy for stopping smoking: what advantages does it offer? Drugs. 2010;70(6):643–650. doi: 10.2165/11536100-000000000-00000
   PubMed Web of Science ®Google Scholar
• FDA 2013. https://www.federalregister.gov/documents/2013/04/02/2013-07528/modifications-to-labeling-of-nicotine-replacement-therapy-products-for-over-the-counter-human-use
   Google Scholar
• Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction. 2012;107(7):1349–1353. doi: 10.1111/j.1360-0443.2012.03801.x
   PubMed Web of Science ®Google Scholar
• Hughes JR, Solomon LJ, Peasley-Miklus CE, et al. Effectiveness of continuing nicotine replacement after a lapse: A randomized trial. Add Behav. 2018;76:68–81. doi: 10.1016/j.addbeh.2017.07.023
   PubMed Web of Science ®Google Scholar
• Piper ME, Fiore MC, Smith SS, et al. Identifying effective intervention components for smoking cessation: a factorial screening experiment. Addiction. 2016;111(1):129–141. doi: 10.1111/add.13162
   PubMed Web of Science ®Google Scholar
• Schnoll RA, Goelz PM, Veluz-Wilkins A, et al. Long-term nicotine replacement therapy: a randomized clinical trial. JAMA Intern Med. 2015;175(4):504–511. doi: 10.1001/jamainternmed.2014.8313
   PubMed Web of Science ®Google Scholar
• Tonstad S, Tonnesen P, Hajek P, et al. Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA. 2006;296:64–71. doi: 10.1001/jama.296.1.64
   PubMed Web of Science ®Google Scholar
• Suissa K, Larivière J, Eisenberg MJ, et al. Efficacy and safety of smoking cessation interventions in patients with cardiovascular disease: a network meta-analysis of randomized controlled trials. Circ Cardiovasc Qual Outcomes. 2017;10(1):e002458. doi: 10.1161/CIRCOUTCOMES.115.002458
   PubMed Web of Science ®Google Scholar
• Stead LF, Koilpillai P, Fanshawe TR, et al. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;(3). CD008286. doi: 10.1002/14651858.CD008286.pub3.
   Web of Science ®Google Scholar
• Windle SB, Dehghani P, Roy N, et al. Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital. CMAJ. 2018;190(12):E347–E354. doi: 10.1503/cmaj.170377
   PubMed Web of Science ®Google Scholar
• Melzer AC, Feemster LC, Collins MP, et al. Utilization and effectiveness of pharmacotherapy for tobacco use following admission for exacerbation of COPD. J Hosp Med. 2016;11(4):257–263. doi: 10.1002/jhm.2519
   PubMed Web of Science ®Google Scholar
• Pack QR, Priya A, Lagu TC, et al. Smoking cessation pharmacotherapy among smokers hospitalized for coronary heart disease. JAMA Intern Med. 2017;177(10):1525–1527. doi: 10.1001/jamainternmed.2017.3489
   PubMed Web of Science ®Google Scholar
• Stefan MS, Pack Q, Shieh MS, et al. The association of nicotine replacement therapy with outcomes among smokers hospitalized for a major surgical procedure. Chest. 2020;157(5):1354–1361. doi: 10.1016/j.chest.2019.10.054
   PubMed Web of Science ®Google Scholar
• Slattery C, Freund M, Gillham K, et al. Increasing smoking cessation care across a network of hospitals: an implementation study. Implement Sci. 2016;11(1):28. doi: 10.1186/s13012-016-0390-x
   PubMedGoogle Scholar
• Pagidipati NJ, Hellkamp A, Thomas L, et al. Use of prescription smoking cessation medications after myocardial infarction among older patients in community practice. JAMA Cardiol. 2017;2(9):1040–1042. doi: 10.1001/jamacardio.2017.2369
   PubMed Web of Science ®Google Scholar
• Chehab OM, Dakik HA. Interventions for smoking cessation in patients admitted with acute coronary syndrome: a review. Postgrad Med J. 2018;94(1108):116–120. doi: 10.1136/postgradmedj-2017-135040
   PubMed Web of Science ®Google Scholar
• Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (eagles): a double-blind, randomised, placebo-controlled clinical trial. Lancet. 2016;387(10037):2507–2520. doi: 10.1016/S0140-6736(16)30272-0
   PubMed Web of Science ®Google Scholar
• Pack QR, Priya A, Lagu TC, et al. Short-term safety of nicotine replacement in smokers hospitalized with coronary heart disease. J Am Heart Assoc. 2018;7(18):e009424. doi: 10.1161/JAHA.118.009424
   PubMed Web of Science ®Google Scholar
• Benowitz NL, Pipe A, West R, et al. Cardiovascular safety of varenicline, bupropion, and nicotine patch in smokers: a randomized clinical trial. JAMA Intern Med. 2018;178(5):622–631. doi: 10.1001/jamainternmed.2018.0397
   PubMed Web of Science ®Google Scholar
• Woolf KJ, Zabad MN, Post JM, et al. Effect of nicotine replacement therapy on cardiovascular outcomes after acute coronary syndromes. Am J Cardiol. 2012;110(7):968–970. doi: 10.1016/j.amjcard.2012.05.028
   PubMed Web of Science ®Google Scholar
• Mills EJ, Thorlund K, Eapen S, et al. Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis. Circulation. 2014;129(1):28–41. doi: 10.1161/CIRCULATIONAHA.113.003961
   PubMed Web of Science ®Google Scholar
• Brokowski L, Chen J, Tanner S. High-dose transdermal nicotine replacement for tobacco cessation. Am J Health Syst Pharm. 2014;71(8):634–638. doi: 10.2146/ajhp130543
   PubMed Web of Science ®Google Scholar
• Pack QR, Bauldoff G, Lichtman SW, et al. Prioritization, development, and validation of American association of cardiovascular and pulmonary rehabilitation performance measures. J Cardiopulm Rehabil Prev. 2018;38(4):208. doi: 10.1097/HCR.0000000000000358
   PubMed Web of Science ®Google Scholar
• Vander Weg MW, Cozad AJ, Howren MB, et al. An individually-tailored smoking cessation intervention for rural veterans: a pilot randomized trial. BMC Public Health. 2016;16(1):1–1. doi: 10.1186/s12889-016-3493-z
   PubMedGoogle Scholar
• CDC. Health disparities related to Commercial tobacco and Advancing health Equityhttps://www.Cdc.gov/tobacco/health-equity/index.Htm. Accessed 10/20/23.
   Google Scholar
• Peters SA, Muntner P, Woodward M. Sex differences in the prevalence of, and trends in, cardiovascular risk factors, treatment, and control in the United States, 2001 to 2016. Circulation. 2019;139(8):1025–1035. doi: 10.1161/CIRCULATIONAHA.118.035550
   PubMed Web of Science ®Google Scholar
• Cepeda-Benito A, Doogan NJ, Redner R, et al. Trend differences in men and women in rural and urban US settings. Preventive med. 2018;117:69–75. doi: 10.1016/j.ypmed.2018.04.008
   PubMed Web of Science ®Google Scholar
• Khadanga S, Yant B, Savage PD, et al. Objective measure of smoking status highlights disparities by sex. Am Heart J Plus. 2022;17:100171. doi: 10.1016/j.ahjo.2022.100171
   PubMedGoogle Scholar
• Zavorsky GS, Tesler J, Rucker J, et al. Rates of carbon monoxide elimination in males and females. Physiol Rep. 2014;2(12):e12237. doi: 10.14814/phy2.12237
   PubMedGoogle Scholar
• Henningfield JE, Stitzer ML, Griffiths RR. Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addict Behav. 1980;5(3):265–272. doi: 10.1016/0306-4603(80)90049-0
   PubMed Web of Science ®Google Scholar
• Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011;378(9799):1297–1305. doi: 10.1016/S0140-6736(11)60781-2
   PubMed Web of Science ®Google Scholar
• Palmer J, Lloyd A, Steele L, et al. Differential risk of ST-Segment elevation myocardial infarction in male and female smokers. J Am Coll Cardiol. 2019;73(25):3259–3266. doi: 10.1016/j.jacc.2019.03.525
   PubMed Web of Science ®Google Scholar
• Vasiljevic Z, Scarpone M, Bergami M, et al. Smoking and sex differences in first manifestation of cardiovascular disease. Atherosclerosis. 2021;330:43–51. doi: 10.1016/j.atherosclerosis.2021.06.909
   PubMed Web of Science ®Google Scholar
• Smith PH, Bessette AJ, Weinberger AH, et al. Sex/Gender differences in smoking cessation: a review. Prev Med. 2016;92:135–140. doi: 10.1016/j.ypmed.2016.07.013
   PubMed Web of Science ®Google Scholar
• Smith PH, Kasza KA, Hyland A, et al. Gender differences in medication use and cigarette smoking cessation: results from the International tobacco control four country survey. Nicotine Tob Res. 2015;17(4):463–472. doi: 10.1093/ntr/ntu212
   PubMed Web of Science ®Google Scholar
• Piper ME, Cook JW, Schlam TR, et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res. 2010;12(6):647–657. doi: 10.1093/ntr/ntq067
   PubMed Web of Science ®Google Scholar
• Leventhal AM, Dai H, Higgins ST. Smoking cessation prevalence and inequalities in the United States: 2014-2019. JNCI. 2022;114(3):381–390. doi: 10.1093/jnci/djab208
   PubMedGoogle Scholar
• Castaldelli-Maia JM, Nesoff ED, Lima DR, et al. The first day of smoking abstinence is more challenging for women than men: a meta-analysis and meta-regression across 12 low-and middle-income countries. Add Behav. 2022;128:107234. doi: 10.1016/j.addbeh.2021.107234
   PubMed Web of Science ®Google Scholar
• Dieleman LA, van Peet PG, Vos HMM. Gender differences within the barriers to smoking cessation and the preferences for interventions in primary care a qualitative study using focus groups in the Hague, the Netherlands. BMJ Open. 2021;11(1):e042623. doi: 10.1136/bmjopen-2020-042623
   PubMed Web of Science ®Google Scholar
• Suh M, Im B, Lee HJ, et al. Smoking cessation strategies for women: an analysis of smoking cessation determinants among Korean female smokers participating in a smoking cessation outreach program. Health Promot Perspect. 2023;13(1):54–60. doi: 10.34172/hpp.2023.07
   PubMed Web of Science ®Google Scholar
• Minian N, Penner J, Voci S, et al. Woman focused smoking cessation programming: a qualitative study. BMC Women’s Health. 2016;16(1):1–8. doi: 10.1186/s12905-016-0298-2
   PubMedGoogle Scholar
• Yarnell J, Yu S, McCrum E, et al. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME study. Int J Epidemiol. 2005;34(2):268–275. doi: 10.1093/ije/dyh267
   PubMed Web of Science ®Google Scholar
• Matetic A, Bharadwaj A, Mohamed MO, et al. Socioeconomic status and differences in the management and outcomes of 6.6 million US patients with acute myocardial infarction. Am J Cardiol 15. 2020;129:10–18. doi: 10.1016/j.amjcard.2020.05.025
   PubMed Web of Science ®Google Scholar
• Sun EY, Jadotte YT, Halperin W. Disparities in cardiac rehabilitation participation in the United States: a SYSTEMATIC REVIEW and META-ANALYSIS. J Cardiopulm Rehabil Prev. 2017;37(1):2–10. doi: 10.1097/HCR.0000000000000203
   PubMed Web of Science ®Google Scholar
• Fang J, Ayala C, Luncheon C. Use of outpatient cardiac rehabilitation among heart attack survivors—20 States and the District of Columbia, 2013 and four States, 2015. MMWR Morb Mortal Wkly Rep. 2017;66(33):869–873. doi: 10.15585/mmwr.mm6633a1
   PubMed Web of Science ®Google Scholar
• Ades PA, Khadanga S, Savage PD, et al. Enhancing participation in cardiac rehabilitation: focus on underserved populations. Prog Cardiovasc Dis. 2022 Jan 1;70:102–110. doi: 10.1016/j.pcad.2022.01.003
   PubMed Web of Science ®Google Scholar
• Khadanga S, Gaalema DE, Savage P, et al. Underutilization of cardiac rehabilitation in women: BARRIERS and SOLUTIONS. J Cardiopulm Rehabil Prev. 2021;41(4):207–213. doi: 10.1097/HCR.0000000000000629
   PubMed Web of Science ®Google Scholar
• Farah M, Abdallah M, Szalai H, et al. Association between patient cost sharing and cardiac rehabilitation adherence. Mayo Clic Proce. 2019;94(12):2390–2398.
   Google Scholar
• Gaalema DE, Elliott RJ, Savage PD, et al. Financial incentives to increase cardiac rehabilitation participation among low-socioeconomic status patients: a randomized clinical trial. JACC Heart Fail. 2019;7(7):537–546. doi: 10.1016/j.jchf.2018.12.008
   PubMed Web of Science ®Google Scholar
• Yant B, Kromer L, Savage PD, et al. Financial incentives and case management to improve cardiac rehabilitation participation among patients with lower socio-economic status: rationale and protocol for a randomized controlled trial. Contemp Clin Trials. 2023;129:107174. doi: 10.1016/j.cct.2023.107174
   PubMed Web of Science ®Google Scholar
• Taylor G, McNeill A, Girling A, et al. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ. 2014 Feb 13;348(feb13 1):g1151–g1151. doi: 10.1136/bmj.g1151
   PubMedGoogle Scholar
• Cobb NK, Abrams DB. The FDA, e-cigarettes, and the demise of combusted tobacco. N Engl J Med. 2014;371(16):1469–1471. doi: 10.1056/NEJMp1408448
   PubMed Web of Science ®Google Scholar